DE69715883D1 - STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB - Google Patents

STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB

Info

Publication number
DE69715883D1
DE69715883D1 DE69715883T DE69715883T DE69715883D1 DE 69715883 D1 DE69715883 D1 DE 69715883D1 DE 69715883 T DE69715883 T DE 69715883T DE 69715883 T DE69715883 T DE 69715883T DE 69715883 D1 DE69715883 D1 DE 69715883D1
Authority
DE
Germany
Prior art keywords
interferones
lab
stabilization
rubber
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715883T
Other languages
German (de)
Other versions
DE69715883T2 (en
Inventor
Peter R Rothschild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FERONPATENT Ltd
Original Assignee
FERONPATENT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FERONPATENT Ltd filed Critical FERONPATENT Ltd
Publication of DE69715883D1 publication Critical patent/DE69715883D1/en
Application granted granted Critical
Publication of DE69715883T2 publication Critical patent/DE69715883T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69715883T 1996-05-09 1997-05-09 STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB Expired - Fee Related DE69715883T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9600433 1996-05-09
PCT/IB1997/000531 WO1997041885A1 (en) 1996-05-09 1997-05-09 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets

Publications (2)

Publication Number Publication Date
DE69715883D1 true DE69715883D1 (en) 2002-10-31
DE69715883T2 DE69715883T2 (en) 2003-07-31

Family

ID=11004429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715883T Expired - Fee Related DE69715883T2 (en) 1996-05-09 1997-05-09 STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB

Country Status (8)

Country Link
EP (1) EP0920329B1 (en)
AP (1) AP1168A (en)
AT (1) ATE224725T1 (en)
AU (1) AU2401197A (en)
DE (1) DE69715883T2 (en)
DK (1) DK0920329T3 (en)
ES (1) ES2184084T3 (en)
WO (1) WO1997041885A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0920329T3 (en) * 1996-05-09 2003-01-27 Feronpatent Ltd Stabilization of interferons in aqueous solution with gum arabic
JP2001526662A (en) * 1997-05-09 2001-12-18 フェロンパテント リミテッド Stabilization of interferon in aqueous solution for the production of sublingual tablets
NZ335005A (en) * 1997-08-01 2000-12-22 Toray Industries Method for stabilizing cytokine using a compound arabic acid or the like
FR2836379B1 (en) * 2002-02-28 2007-06-01 Dit Bon Michel Betend SOLID GALENIC FORMS OF HOMEOPATHIC MEDICAMENTS, INCLUDING ALLERGENS OR ANTIGENS, IN HOMEOPATHIC DILUTIONS FOR EXTENDED PREPARATION FOR SINGLE INDIVIDUAL FOR SUBLINGUAL DELIVERY
JP2008501639A (en) * 2004-04-23 2008-01-24 ノベシン リミテッド Methods and kits for stabilizing, protecting and solubilizing proteins
EP1749018B1 (en) * 2004-04-23 2014-10-22 Expedeon Limited Methods and kits for stabilising, protecting and solubilising proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (en) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Method of making a dry, homeopathic remedy.
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
FR2619714B1 (en) * 1987-09-02 1991-07-12 Medibrevex NOVEL GALENIC FORMS OF THEOPHYLLIN FOR PER- AND SUBLINGUAL ADMINISTRATION
CA2024046A1 (en) * 1989-09-28 1991-03-29 Alberto Ferro Stabilized leukocyte-interferons
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
DK0920329T3 (en) * 1996-05-09 2003-01-27 Feronpatent Ltd Stabilization of interferons in aqueous solution with gum arabic

Also Published As

Publication number Publication date
EP0920329A1 (en) 1999-06-09
DK0920329T3 (en) 2003-01-27
AP9901682A0 (en) 1999-12-31
WO1997041885A1 (en) 1997-11-13
ATE224725T1 (en) 2002-10-15
ES2184084T3 (en) 2003-04-01
EP0920329B1 (en) 2002-09-25
DE69715883T2 (en) 2003-07-31
AU2401197A (en) 1997-11-26
AP1168A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
BR9810801B1 (en) aqueous liquid composition.
IT1271014B (en) 3-ARIL-BENZOFURANONI AS STABILIZING AGENTS
DE69700813T2 (en) USE OF STABLE AMINO-FUNCTIONAL LATEX IN AQUEOUS INKS
ATE272313T1 (en) EMULSION CONCENTRATE CONTAINING ONE OR MORE PEST CONTROL AGENTS
DE60002696D1 (en) ELIMINATION OF REDUNDANCY IN THE PERSISTENCE OF OBJECT GRAPHS
DE69518454T2 (en) Estimation of excitation parameters
DE69801676D1 (en) AQUEOUS EMULSIONS OF FISCHER-DROPSCHPARAFFIN
DE69530210D1 (en) BY DETERGENTS SPONSORED IMMUNOTESTS OF PHARMACOLOGICAL ACTIVE SUBSTANCES
DE69512702T2 (en) Aqueous ink composition
DE69822366D1 (en) Aqueous emulsion composition
ATE440086T1 (en) CONTROL OF ARTHROPODS IN ANIMALS
DE69715883T2 (en) STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB
DE69419207T2 (en) Device for determining the concentration of various ions in aqueous solutions
DE60006799D1 (en) ORAL-ADDABLE SOLUTION OF PRUCALOPRID
DE59603739D1 (en) LIQUID CONSTRUCTION OF THICKENING AGENTS (II)
DE69609600D1 (en) IMPROVED CHEMILUMINESCENT SOLUTION
DE69500604T2 (en) Aqueous primer composition
DE69500167T2 (en) Aqueous solution for surface treatment of metals
DE69500605T2 (en) Aqueous primer composition
DE69729746D1 (en) HIGHLY STABLE AQUEOUS SOLUTION OF PARTLY SOAPED VINYLESTER RESIN
DE69917623D1 (en) OPHTHALMOLOGICAL SOLUTION CONTAINING GLYCOGEN
DE69515179D1 (en) COMPONENT FOR ESTABLISHING STRUCTURES
DE69602155D1 (en) Improving brandies
DE69604890T2 (en) LIQUID COMPOSITION FOR STABILIZING BYPIRIDINIUM HERBICIDES
DE69716598T2 (en) STABILIZATION OF PAINTINGS BY SPIROINDER DERIVATIVES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee